What Does OncoHost Do?

Total employees56
HeadquartersBinyamina
Founded2017

OncoHost is a commercial-stage precision oncology company revolutionizing the approach to cancer treatment. Their core offering, the PROphet® platform, utilizes advanced AI and machine learning algorithms to analyze changes in blood-based proteomic profiles. This enables oncologists to predict patient response to specific cancer therapies, primarily immunotherapies, helping to personalize treatment strategies, improve patient outcomes, and reduce ineffective treatments. OncoHost aims to provide actionable, real-time insights to guide clinical decision-making in oncology.

Where Is OncoHost's Headquarters?

HQ Function

Serves as the central hub for research and development of its AI-powered precision oncology platform, PROphet®, as well as global strategic management, corporate operations, and bioinformatics.

Notable Features:

Modern laboratory and office facilities situated within the Binyamina Industrial Zone, equipped for advanced proteomic analysis, AI model development, and computational research.

Work Culture:

Characterized by a highly innovative, collaborative, and research-intensive environment. It brings together experts in oncology, data science, AI, and molecular biology, all focused on a patient-centric mission to transform cancer care.

HQ Significance:

Strategically located in Israel, a global center for technological and biomedical innovation, enabling access to top-tier talent and a supportive ecosystem for growth in the precision medicine field. It's the nerve center for OncoHost's pioneering work.

Values Reflected in HQ: The headquarters' focus on cutting-edge research, data-driven insights, and advanced technology reflects OncoHost's core values of innovation, precision, scientific rigor, and patient-centricity in oncology.

Location:

OncoHost operates with a global outlook, with its primary R&D and corporate functions headquartered in Israel and significant laboratory and commercial operations in the United States (Research Triangle Park, NC). The company collaborates internationally with leading academic institutions, hospitals, and pharmaceutical partners on clinical trials and research initiatives to validate and expand the applications of its PROphet® platform worldwide. Their services and technology are designed for global applicability in oncology.

Street Address:

7 Hanagar St, Binyamina Industrial Park

City:

Binyamina

State/Province:

Haifa District

Country:

Israel

Where Else Does OncoHost Operate Around the World?

Research Triangle Park, North Carolina, USA

Address: 7020 Kit Creek Rd, Suite 250, Research Triangle Park, NC 27709, USA

Serves as OncoHost's operational hub in North America, facilitating engagement with the U.S. healthcare system, supporting clinical studies, fostering collaborations with U.S. research institutions and pharmaceutical companies, and spearheading commercial activities in the region.

Buying Intent Signals for OncoHost

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading OncoHost? Meet the Executive Team

As of April 2025, OncoHost' leadership includes:

Ofer Sharon, MD - Chief Executive Officer
Prof. Yuval Shaked, PhD - Co-Founder & Chief Scientific Officer
Chris Hall - President, OncoHost USA & Chief Business Officer
Dror Yarkoni - Chief Financial Officer
Eran Chikoshinski - Chief Commercial Officer
Matan Arad (Ben Baruch), PhD - Vice President Research & Development
Itsik Spourkh, PhD - Vice President Operations

Who's Investing in OncoHost?

OncoHost has been backed by several prominent investors over the years, including:

OurCrowd
Picus Capital
StageOne Ventures
Prytango
Spring Mountain Capital
BioConnect Investment (BCI)
ReThink Israel
HeteroSon Medical Systems

What Leadership Changes Has OncoHost Seen Recently?

Hire2
Exits0

In the past 12 months, OncoHost has strengthened its executive team with key appointments in finance and commercial operations, reflecting its growth and focus on market expansion. No major executive departures have been publicly announced during this period.

New Appointments:

Dror Yarkoni, Dror Yarkoni appointed as new Chief Financial Officer, bringing extensive financial leadership experience to OncoHost.
Eran Chikoshinski, Eran Chikoshinski joined OncoHost as Chief Commercial Officer to spearhead global commercial strategy and execution.

What Technology (Tech Stack) Is Used byOncoHost?

Discover the tools OncoHost uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

OncoHost Email Formats and Examples

OncoHost likely utilizes common professional email formats. Based on typical company structures of its size and industry, the most probable format is a combination of the employee's first initial and last name, or first name and last name separated by a dot.

Common formats include [first_initial][last]@oncohost.com (e.g., jsmith@oncohost.com) or [first].[last]@oncohost.com (e.g., john.smith@oncohost.com).

Format

osharon@oncohost.com

Example

90%

Success rate

What's the Latest News About OncoHost?

Business WireJune 3, 2024

OncoHost Presents New Data at ASCO 2024 Demonstrating PROphet® Platform's Ability to Predict Clinical Benefit and Optimize Treatment Strategies for NSCLC Patients

OncoHost shared promising new data at the American Society of Clinical Oncology (ASCO) Annual Meeting, showcasing the PROphet® platform's capability to predict clinical outcomes and inform treatment decisions for non-small cell lung cancer (NSCLC) patients undergoing immunotherapy....more

OncoHost NewsMay 21, 2024

OncoHost Announces First Patient Enrolled in PreRectal Cancer Study

OncoHost announced the enrollment of the first patient in its 'PreRectal' clinical study. This prospective trial aims to evaluate the PROphet® platform's ability to predict response to neoadjuvant therapy in patients with locally advanced rectal cancer (LARC)....more

Business WireApril 9, 2024

OncoHost Announces Issuance of U.S. Patent for AI-Powered Blood Test to Predict Responsiveness to Immunotherapy Treatment

OncoHost secured a U.S. patent for its innovative AI-driven blood test technology designed to predict patient responsiveness to immunotherapy, further solidifying its intellectual property portfolio in precision oncology....more

GlobeNewswireFebruary 20, 2024

OncoHost Study Validates PROphet® Platform’s Ability to Predict Immunotherapy Response in Melanoma Patients

A study published in the Journal for ImmunoTherapy of Cancer (JITC) validated the PROphet® platform's ability to predict melanoma patients' response to immunotherapy using pre-treatment blood samples, marking a significant step in personalized melanoma care....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including OncoHost, are just a search away.